GlaxoSmithKline granted FDA approval for drug to treat multiple myeloma
August 06, 2020 at 11:19 AM EDT
GlaxoSmithKline said the treatment was granted an accelerated approval based on patient response rate in clinical trials.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.